Foreign Minister Bruno Rodriguez, in a message broadcast on X, highlighted his government’s demonstrated interest following the reactivation of production of 16 cytostatic drugs for the National Program for the Care of Cancer Patients.
This comes, the island’s foreign minister emphasized, after a significant investment process carried out “amid severe economic limitations, caused by the extreme intensification of the blockade and an unprecedented energy embargo.” Rodriguez emphasized the significance of these medications, produced by AICA Laboratories, part of the Biotechnology and Pharmaceutical Industries Group (Biocubafarma), underscoring that “each drug produced at this plant represents sovereignty, hope, and a commitment to the right to health for all Cubans.”
Previously, following last week’s announcement of the plant’s reactivation, Cuban President Miguel Diaz-Canel referred to the event in similar terms, calling it great news.
The reactivation of production of 16 cytostatic drugs for the National Cancer Patient Care Program is not an isolated event and is a clear example of how the Cuban biotechnology industry and the Public Health System are working in complete partnership to ensure the availability of essential medicines during this critical time.
jdt/rc/jqo
